Licensing Partnerships DNA Ink specializes in negotiating deals to maximize asset value across market forecasting, financial valuation, deal strategy and term sheet negotiation, offering end-to-end support from data package coordination to deal execution. Target sales with biotech startups, universities and mid-size biopharma assets needing licensing or co-development deals.

Valuation and Forecast Leverage DNA Ink's strengths in market forecasting and financial valuation to help clients price assets for licensing, collaboration or fundraising rounds, enabling more favorable terms and attracting strategic partners.

Agile Deal Partner As a small firm with big biotech and pharma experience, DNA Ink offers agile, high-touch deal management, fast response times and cost-efficient engagement models ideal for early-stage assets and startups navigating complex partnering processes.

SF Biotech Hub Based in San Francisco, DNA Ink can tap into the local biotech ecosystem including universities, incubators, and venture networks to source opportunities and connect clients with potential licensees or strategic partners.

Compliance Trust Security-forward operations evidenced by HSTS, X-Content-Type-Options and analytics tools can be positioned as a differentiator for confidential data handling in deal packets and term sheets, offering secure data room and negotiation processes.